Controversies in borderline ovarian tumors
Borderline ovarian tumors (BOTs) represent about 15% to 20% of all ovarian malignancies and differ from invasive ovarian cancers (IOCs) by many characters. Historically, standard management of BOT is peritoneal washing cytology, hysterectomy, bilateral salpingo-oophorectomy, omentectomy, complete pe...
Main Authors: | , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620372/ |